These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26880104)

  • 1. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
    Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
    Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock.
    Jie H; Li Y; Pu X; Ye J
    Am J Med Sci; 2017 Mar; 353(3):242-246. PubMed ID: 28262210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
    Hansen MB; Rasmussen LS; Garred P; Pilely K; Wahl AM; Perner A; Madsen MB; Hedegaard ER; Simonsen U; Hyldegaard O
    Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma pentraxin 3 levels in patients with septic shock admitted to intensive care.
    Perez-San Martin S; Suberviola B; Garcia-Unzueta MT; Lavin BA; Campos S; Santibañez M
    PLoS One; 2020; 15(12):e0243849. PubMed ID: 33301518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
    Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
    Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
    Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
    Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
    Hansen MB; Simonsen U; Garred P; Hyldegaard O
    BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions.
    Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS
    BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
    Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
    Front Immunol; 2020; 11():17. PubMed ID: 32082310
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
    Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
    J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection.
    Hedetoft M; Hansen MB; Madsen MB; Johansen JS; Hyldegaard O
    BMC Infect Dis; 2021 Oct; 21(1):1046. PubMed ID: 34627195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections.
    Horn DL; Shen J; Roberts E; Wang TN; Li KS; O'Keefe GE; Cuschieri J; Bulger EM; Robinson BRH
    J Trauma Acute Care Surg; 2020 Jul; 89(1):186-191. PubMed ID: 32102045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission Pentraxin-3 Level Predicts Severity of Community-Acquired Pneumonia Independently of Etiology.
    Luo Q; He X; Ning P; Zheng Y; Yang D; Xu Y; Shang Y; Gao Z
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800117. PubMed ID: 30557448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source of Circulating Pentraxin 3 in Septic Shock Patients.
    Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
    Front Immunol; 2018; 9():3048. PubMed ID: 30687307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.